The lifetime risk of breast and ovarian cancer in BRCA1 mutation carriers has been estimated to be as high as 87% [107], and elevated risks of other cancer types, including gastric, pancreatic, prostate and colorectal, have also been identified, with a frequency range of 20–60% [108]. This evidence concerns the gene BRCA1 and ovarian cancer.